Progenics Pharma (PGNX) Receives Milestone Payment Tied to FDA Approval of RELISTOR (VRX)
Tweet Send to a Friend
Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) announced that it has received a $50 million milestone payment from its worldwide collaboration partner ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
